2019
DOI: 10.1101/614859
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein

Abstract: AbstractStudies on biological functions ofN6-methyladenosine (m6A) modification in mRNA have sprung up in recent years. Here we construct and characterize a CRISPR-Cas13b-based tool for the first time that targeted m6A methylation of mRNA by fusing the catalytically dead Type VI-B Cas13 enzyme from Prevotella sp.P5-125 (dPspCas13b) with the m6A demethylase ALKBH5, whic… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 44 publications
1
0
0
Order By: Relevance
“…More broadly, this programmable, small molecule-controllable RNA effector design provides a generalizable approach to study the RNA regulatory dynamics of an ever-growing list of known RNA regulatory proteins in live cells. Several recent advances in understanding the regulatory role of individual chemical modifications, such as m 6 A, have relied on programmable site-specific targeting technology such as RNA-targeting Cas9 (RCas9) or Cas13. For example, a programmable dCas13b-FTO protein was instrumental in demonstrating the role m 6 A modifications on specific chromosome-associated regulatory RNAs play in transcription . Despite these advances in understanding regulatory roles of m 6 A on specific transcripts, the temporal component of their regulation has yet to be elucidated.…”
Section: Discussionsupporting
confidence: 61%
“…More broadly, this programmable, small molecule-controllable RNA effector design provides a generalizable approach to study the RNA regulatory dynamics of an ever-growing list of known RNA regulatory proteins in live cells. Several recent advances in understanding the regulatory role of individual chemical modifications, such as m 6 A, have relied on programmable site-specific targeting technology such as RNA-targeting Cas9 (RCas9) or Cas13. For example, a programmable dCas13b-FTO protein was instrumental in demonstrating the role m 6 A modifications on specific chromosome-associated regulatory RNAs play in transcription . Despite these advances in understanding regulatory roles of m 6 A on specific transcripts, the temporal component of their regulation has yet to be elucidated.…”
Section: Discussionsupporting
confidence: 61%